P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG-TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML-001 TRIAL OF ORAL AZACITIDINE

oleh: A. H. Wei, H. Döhner, H. Sayar, F. Ravandi, P. Montesinos, H. Dombret, D. Selleslag, K. Porkka, J.-H. Jang, B. Skikne, C. Beach, T. Prebet, G. Zhang, A. Risueño, M. Ugidos Guerrero, W. L. See, D. Menezes, G. J. Roboz